Professor Anders Fasth joins the scientific advisory board
Lipum has developed a biological drug candidate for treatment of chronic inflammatory diseases and aim for a better treatment of juvenile idiopathic arthritis (JIA), that affects children. Therefore, the scientific advisory board of the company is now strengthened with Anders Fasth, senior professor of pediatric immunology at the University of Gothenburg and a senior consultant at Queen Silvia Children's Hospital in Gothenburg, Sweden.Anders Fasth comments: “I started treating children with rheumatism several decades ago. We today have effective medicines to choose from, but still many